AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Vildanat-M 500 Tablet SR

Prescription Icon
Prescription Required

Marketer

Natco Pharma Ltd

Salt Composition

Metformin (500mg) + Vildagliptin (50mg)

Overview Vildanat-M 500 Tablet SR

Vildanat-M 500 SR tablets combine two medications to effectively manage elevated blood glucose in patients with type 2 diabetes. This dual action helps prevent serious diabetic complications like renal impairment and vision loss, potentially lowering the risk of cardiovascular events such as heart attack or stroke. Vildanat-M 500 SR may be used as monotherapy or in conjunction with other antidiabetic agents. Optimal therapeutic response requires adherence to a prescribed diet and regular physical activity. Dosage is individualized based on your health status, glucose levels, and concurrent medications. Consuming this medication with food minimizes gastrointestinal upset. Consistent daily dosing, at the same time each day, maximizes efficacy; discontinuation should only occur under physician guidance. This treatment actively regulates blood sugar, mitigating the risk of future complications. Continued commitment to your physician's dietary and exercise plan is crucial. Lifestyle choices significantly impact diabetes management. Commonly reported adverse effects include diarrhea, nausea, vomiting, dyspepsia, headache, pharyngitis, asthenia, GERD, hyperhidrosis, and anorexia. Hypoglycemia, a potential side effect when used with insulin or sulfonylureas, necessitates understanding its recognition and management. This medication isn't universally suitable. Prior to initiating treatment, inform your doctor of any history of kidney, liver, or heart disease, pancreatic disorders, or significant alcohol consumption. Pregnant or lactating individuals require medical consultation before use. Potential drug interactions necessitate disclosure of all medications to your physician. Alcohol consumption should be minimized due to its hypoglycemic effect. Your doctor will monitor kidney function and blood glucose levels throughout treatment.

Primary Ingredients of Vildanat-M 500 Tablet SR

No information provided. Please provide the text you wish to be rewritten.

Uses of Vildanat-M 500 Tablet SR

Managing Type 2 Diabetes

Major Benefits of Vildanat-M 500 Tablet SR:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Vildanat-M 500 Tablet SR whole; avoid crushing, chewing, or breaking it. Administer this medication with food.

Common Side effects of Vildanat-M 500 Tablet SR:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Vildanat-M 500 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Vildanat-M 500mg sustained-release tablets. Ingest the tablets whole; avoid crushing, chewing, or breaking them. Administer this medication with a meal.

How Vildanat-M 500 Tablet SR works:

Vildanat-M 500mg sustained-release tablets contain a dual-action antidiabetic formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Vildanat-M 500 Tablet SR and alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Vildanat-M 500 Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release Vildanat-M 500mg tablet is likely not safe for use while breastfeeding. Available human data indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

For individuals with kidney impairment, Vildanat-M 500mg sustained-release tablets require careful administration. Dosage modifications for Vildanat-M 500mg sustained-release tablets may be necessary. Physician consultation is advised.

LiverLiverUNSAFE

Use of Vildanat-M 500 SR tablets is likely inadvisable for individuals with hepatic impairment and should be avoided. Medical advice is recommended.

What if you forget to take Vildanat-M 500 Tablet SR :

Should you forget a dose of Vildanat-M 500mg sustained-release tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Vildanat-M 500 Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Vildanat-M 500 Tablet SR

Vildanat-M 500 Tablet SR rarely causes hypoglycemia by itself; however, low blood sugar can occur if insufficient calories are consumed. Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, and shakiness, particularly if meals are missed or delayed, alcohol is consumed, excessive exercise occurs, or other antidiabetic medications are used concurrently. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Nausea and vomiting are possible side effects of Vildanat-M 500 Tablet SR. If vomiting occurs, sip small amounts of water or other fluids frequently. Persistent vomiting or signs of dehydration (dark, strong-smelling urine, infrequent urination) require immediate medical attention. Consult your doctor before taking any other medication.
Vildanat-M 500 Tablet SR is contraindicated in patients allergic to its components or excipients. It should also not be used by individuals with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container, following the storage instructions provided. Dispose of any unused medication properly and keep it out of reach of children, pets, and others.
Vildanat-M 500 SR tablets combine metformin (a biguanide) and vildagliptin to manage diabetes. Metformin reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is unsuitable for individuals under 18.
Vildanat-M 500 Tablet SR can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect necessitates avoiding the medication in patients with kidney disease, the elderly, or those consuming significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Vildanat-M 500 Tablet SR and seek immediate medical attention.
Prolonged use of Vildanat-M 500 Tablet SR can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia and neurological complications.
Vildanat-M 500 Tablet SR is safe when used as directed by your doctor. However, even with correct usage, you may experience side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, or low blood sugar (hypoglycemia, especially if you also take insulin or sulfonylurea). Report any persistent problems to your doctor.
Vildanat-M 500 Tablet SR
59
MRP 68
13% off